| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.90M | 38.90M | 56.20M | 73.10M | 82.50M | 85.80M |
| Gross Profit | 14.80M | 14.80M | 19.60M | 20.90M | 27.60M | 22.50M |
| EBITDA | 16.40M | 16.40M | 7.50M | 6.90M | 15.80M | -10.50M |
| Net Income | 6.20M | 6.20M | 3.30M | -100.00K | 12.10M | -21.50M |
Balance Sheet | ||||||
| Total Assets | 28.70M | 28.70M | 22.40M | 30.60M | 36.80M | 35.60M |
| Cash, Cash Equivalents and Short-Term Investments | 4.30M | 4.30M | 5.00M | 7.10M | 9.20M | 6.90M |
| Total Debt | 8.80M | 8.80M | 19.90M | 20.00M | 20.20M | 20.40M |
| Total Liabilities | 38.10M | 38.10M | 52.50M | 32.40M | 35.30M | 78.60M |
| Stockholders Equity | -9.40M | -9.40M | -30.10M | -1.80M | 1.50M | -43.00M |
Cash Flow | ||||||
| Free Cash Flow | -3.00M | -1.50M | 2.50M | -800.00K | 2.70M | -4.40M |
| Operating Cash Flow | -3.00M | -1.50M | 4.80M | 1.50M | 5.60M | -4.00M |
| Investing Cash Flow | 14.80M | 14.80M | -2.30M | -2.30M | -2.90M | -400.00K |
| Financing Cash Flow | -14.00M | -14.00M | -4.50M | -1.20M | -500.00K | 5.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | £38.70M | 21.12 | 4.56% | ― | 17.79% | 18.96% | |
63 Neutral | £59.99M | 74.56 | 2.14% | ― | 1.62% | 28.06% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | £36.72M | 36.63 | 11.06% | ― | 11.04% | 64.29% | |
55 Neutral | £26.69M | 3.05 | 63.08% | ― | -1.96% | 28.69% | |
52 Neutral | £15.76M | 2.32 | ― | ― | -30.78% | 86.44% | |
51 Neutral | £16.42M | -32.95 | -3.01% | ― | -19.76% | 4.35% |
Mothercare plc has announced that its Pension Trustee has agreed to further defer pension contributions amounting to £3.0 million until March 2026, allowing the company to focus on growth opportunities and strategic discussions. Despite breaching a liquidity financial covenant, Mothercare continues to receive support from its lender, ensuring sufficient cash flow to maintain operations and explore options to mitigate the pension scheme deficit.
The most recent analyst rating on (GB:MTC) stock is a Hold with a £3.00 price target. To see the full list of analyst forecasts on Mothercare stock, see the GB:MTC Stock Forecast page.
Mothercare plc has released its Annual Report and Accounts for the fiscal year ending 29 March 2025, alongside the Notice of its Annual General Meeting (AGM) scheduled for 12 November 2025. Shareholders are encouraged to submit proxy votes and questions in advance, with all relevant documents available on the company’s website. This announcement is part of Mothercare’s ongoing efforts to maintain transparency with its stakeholders and ensure active shareholder engagement.
Mothercare plc announced its full-year results for 2025, revealing a decline in worldwide retail sales to £230.6 million, down from £280.8 million in 2024. The company is facing challenges due to uncertainties in the Middle East and a reduction in UK sales, leading to decreased profitability. Despite these challenges, Mothercare is focusing on leveraging its strong brand to return to growth, with efforts to expand its franchise operations and explore new markets. The company has made strategic moves, including a joint venture in India and a new license agreement in Turkey, to improve its financial position and support future growth.